Also known as آسٹیوپوروسس مینجمنٹ
General Physician
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Ph.D
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.D (USA)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Internal Medicine Specialist
F.C.P.S. (Medicine), M.D (Gastroentology)
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
Consultant Physician
M.B.B.S., M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Consultant Physician
M.B.B.S., M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures